Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?

Literature DB >> 19568247

Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?

Francesco Boin, Fredrick Wigley.

Abstract

Mesh：

Substances：

Year: 2009 PMID： 19568247 DOI： 10.1038/nrrheum.2009.108

Source DB: PubMed Journal: Nat Rev Rheumatol ISSN： 1759-4790 Impact factor: 20.543

× No keyword cloud information.

6 in total

1. Cyclophosphamide versus placebo in scleroderma lung disease.

Authors: Donald P Tashkin; Robert Elashoff; Philip J Clements; Jonathan Goldin; Michael D Roth; Daniel E Furst; Edgar Arriola; Richard Silver; Charlie Strange; Marcy Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick Wigley; Barbara White; Virginia Steen; Charles Read; Maureen Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky
Journal: N Engl J Med Date: 2006-06-22 Impact factor: 91.245

2. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors: O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal: Ann Rheum Dis Date: 2009-01-15 Impact factor: 19.103

3. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.

Authors: Alice Bérezné; Brigitte Ranque; Dominique Valeyre; Michel Brauner; Yannick Allanore; David Launay; Véronique Le Guern; Jean-Emmanuel Kahn; Louis-Jean Couderc; Joël Constans; Pascal Cohen; Alfred Mahr; Christian Pagnoux; Eric Hachulla; André Kahan; Jean Cabane; Loïc Guillevin; Luc Mouthon
Journal: J Rheumatol Date: 2008-05-01 Impact factor: 4.666

Review 4. Novel treatment approaches to fibrosis in scleroderma.

Authors: Jörg Distler; Oliver Distler
Journal: Rheum Dis Clin North Am Date: 2008-02 Impact factor: 2.670

Review 5. Autoimmunity in systemic sclerosis: current concepts.

Authors: Francesco Boin; Antony Rosen
Journal: Curr Rheumatol Rep Date: 2007-05 Impact factor: 4.592

6. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy.

Authors: Nicolas Hunzelmann; Pia Moinzadeh; Ekkehard Genth; Thomas Krieg; Walter Lehmacher; Inga Melchers; Michael Meurer; Ulf Müller-Ladner; Thorsten M Olski; Christiane Pfeiffer; Gabriela Riemekasten; Eckhard Schulze-Lohoff; Cord Sunderkoetter; Manfred Weber
Journal: Arthritis Res Ther Date: 2009-03-04 Impact factor: 5.156

6 in total

3 in total